{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:31:55Z","timestamp":1794025915064,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04085-4","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T17:04:13Z","timestamp":1743181453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Urinary biomarkers in prediction of subclinical acute kidney injury in pediatric oncology patients treated with nephrotoxic agents"],"prefix":"10.1186","volume":"26","author":[{"given":"Gordana","family":"Milo\u0161evski-Lomi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Kotur-Stevuljevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161an","family":"Paripovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srdjan","family":"Nikolovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Lazi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Predrag","family":"Rodi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Milo\u0161evi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadranka","family":"Mitrovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Vukmir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Petrovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Peco-Anti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"4085_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","volume":"19","author":"C Tang","year":"2023","unstructured":"Tang C, Livingston MJ, Safirstein R, Dong Z. Cisplatin nephrotoxicity: new in-sights and therapeutic implications. Nat Rev Nephrol. 2023;19:53\u201372.","journal-title":"Nat Rev Nephrol"},{"key":"4085_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00467-020-04678-1","volume":"36","author":"M Xiong","year":"2021","unstructured":"Xiong M, Wang L, Su L, Luo W, Li Y, Li L, et al. Acute kidney injury among hospitalized children with cancer. Pediatr Nephrol. 2021;36:171\u20139.","journal-title":"Pediatr Nephrol"},{"key":"4085_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jpeds.2018.12.023","volume":"208","author":"PG Park","year":"2019","unstructured":"Park PG, Hong CR, Kang E, Park M, Lee H, Kang HJ, et al. Acute kidney injury in pediatric cancer patients. J Pediatr. 2019;208:243\u201350.","journal-title":"J Pediatr"},{"key":"4085_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00467-017-3662-z","volume":"33","author":"R Skinner","year":"2018","unstructured":"Skinner R. Late renal toxicity of treatment for childhood malignancy: risk factors, Long-Term outcomes, and surveillance. Pediatr Nephrol. 2018;33:215\u201325.","journal-title":"Pediatr Nephrol"},{"key":"4085_CR5","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/bcp.12282","volume":"77","author":"L van Meer","year":"2014","unstructured":"van Meer L, Moerland M, Cohen AF, Burggraaf J. Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development. Br J Clin Pharmacol. 2014;77:947\u201357.","journal-title":"Br J Clin Pharmacol"},{"key":"4085_CR6","doi-asserted-by":"publisher","first-page":"340e8","DOI":"10.3109\/0284186X.2014.953259","volume":"54","author":"GB Stene","year":"2015","unstructured":"Stene GB, Helbostad JL, Amundsen T, Sorhaug S, Hjelde H, Kaasa S. Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Acta Oncol. 2015;54:340e8.","journal-title":"Acta Oncol"},{"key":"4085_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MOP.0b013e328343f4dd","volume":"23","author":"P Devarajan","year":"2011","unstructured":"Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr. 2011;23:194\u2013200.","journal-title":"Curr Opin Pediatr"},{"key":"4085_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.tox.2011.08.019","volume":"290","author":"K Hosohata","year":"2011","unstructured":"Hosohata K, Ando H, Fujiwara Y, Fujimura A. Vanin-1: A potential biomarker for nephrotoxicant-induced renal injury. Toxicology. 2011;290:82\u20138.","journal-title":"Toxicology"},{"key":"4085_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","volume":"34","author":"GJ Schwartz","year":"1987","unstructured":"Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987;34:571\u201390.","journal-title":"Pediatr Clin North Am"},{"key":"4085_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"KDIGO AKI Work Group","year":"2012","unstructured":"KDIGO AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1\u2013138.","journal-title":"Kidney Int Suppl"},{"key":"4085_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00001813-199108000-00002","volume":"2","author":"J de Kraker","year":"1991","unstructured":"de Kraker J. Ifosfamide in pediatric oncology. Anticancer Drugs. 1991;2:339\u2013411.","journal-title":"Anticancer Drugs"},{"key":"4085_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2217\/phe.10.60","volume":"4","author":"R Skinner","year":"2010","unstructured":"Skinner R. Nephrotoxicity of cancer treatment in children. Pediatr Health. 2010;4:519\u201338.","journal-title":"Pediatr Health"},{"key":"4085_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000312879","volume":"115","author":"F Gaspari","year":"2010","unstructured":"Gaspari F, Cravedi P, Mandal\u00e0 M, Perico N, de Leon FR, Stucchi N, et al. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated Lipocalin excretion: a pilot prospective case-control study. Nephron Clin Pract. 2010;115:154\u201360.","journal-title":"Nephron Clin Pract"},{"key":"4085_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/MCC.0000000000000777","volume":"26","author":"SL Kane-Gill","year":"2020","unstructured":"Kane-Gill SL, Meersch M, Bell M. Biomarker-Guided management of acute kidney injury. Curr Opin Crit Care. 2020;26:556\u201362.","journal-title":"Curr Opin Crit Care"},{"key":"4085_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/pbc.26538","volume":"64","author":"M Sterling","year":"2017","unstructured":"Sterling M, Al-Ismaili Z, McMahon KR, Piccioni M, Pizzi M, Mottes T, et al. Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy. Pediatr Blood Cancer. 2017;64:10.","journal-title":"Pediatr Blood Cancer"},{"key":"4085_CR16","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s00467-015-3178-3","volume":"30","author":"D Carvalho Pedrosa","year":"2015","unstructured":"Carvalho Pedrosa D, Macedo de Oliveira Neves F, Cavalcante Meneses G, Pinheiro Gomes Wirtzbiki G, da Costa Moraes CA, Costa Martins AM, et al. Urinary KIM-1 in children undergoing nephrotoxic antineoplastic treatment: a prospective cohort study. Pediatr Nephrol. 2015;30:2207\u201313.","journal-title":"Pediatr Nephrol"},{"key":"4085_CR17","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00467-013-2421-z","volume":"28","author":"I Ivani\u0161evi\u0107","year":"2013","unstructured":"Ivani\u0161evi\u0107 I, Peco-Anti\u0107 A, Vuli\u010devi\u0107 I, Hercog D, Milovanovi\u0107 V, Kotur-Stevuljevi\u0107 J, et al. L-FABP can be an early marker of acute kidney injury in children. Pediatr Nephrol. 2013;28:963\u20139.","journal-title":"Pediatr Nephrol"},{"key":"4085_CR18","first-page":"46","volume":"22","author":"SM Fang","year":"2021","unstructured":"Fang SM, Hamo S, Chiabi A. Progress in the diagnosis and management of acute kidney injury in children. Health Sci Dis. 2021;22:46\u201351.","journal-title":"Health Sci Dis"},{"key":"4085_CR19","first-page":"197","volume":"66","author":"C Gavrilovici","year":"2018","unstructured":"Gavrilovici C, Luca A, Antoniu SA, Gallaby K, \u015etef\u0103nescu R, St\u00e2rcea M, et al. How nephrotoxic is the cancer therapy in children. Farmacia. 2018;66:197\u2013208.","journal-title":"Farmacia"},{"key":"4085_CR20","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1054\/bjoc.2000.1214","volume":"82","author":"R Skinner","year":"2000","unstructured":"Skinner R, Cotterill SJ, Stevens MCG. Risk factors for nephrotoxicity after Ifosfamide treatment in children: a UKCCSG late effects group study. Br J Cancer. 2000;82:1636\u201345.","journal-title":"Br J Cancer"},{"key":"4085_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ekir.2017.02.008","volume":"2","author":"H Izzedine","year":"2017","unstructured":"Izzedine H, Perazella MA. Anticancer Drug-Induced acute kidney injury. Kidney Int Rep. 2017;2:504\u201314.","journal-title":"Kidney Int Rep"},{"key":"4085_CR22","doi-asserted-by":"publisher","first-page":"SP251","DOI":"10.2131\/jts.34.SP251","volume":"34","author":"M Fujieda","year":"2009","unstructured":"Fujieda M, Matsunaga A, Hayashi A, Tauchi H, Chayama K, Sekine T. Children\u2019s toxicology from bench to bed\u2013 drug-induced renal injury. Nephrotoxicity induced by cisplatin and Ifosfamide in children. J Toxicol Sci. 2009;34:SP251\u20137.","journal-title":"J Toxicol Sci"},{"key":"4085_CR23","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3390\/ijms17111826","volume":"17","author":"K Hosohata","year":"2016","unstructured":"Hosohata K. Role of oxidative stress in Drug-Induced kidney injury. Int J Mol Sci. 2016;17:1826.","journal-title":"Int J Mol Sci"},{"key":"4085_CR24","doi-asserted-by":"publisher","first-page":"F517","DOI":"10.1152\/ajprenal.00291.2005","volume":"290","author":"VS Vaidya","year":"2006","unstructured":"Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Ren Physiol. 2006;290:F517\u201329.","journal-title":"Am J Physiol Ren Physiol"},{"key":"4085_CR25","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1097\/01.ASN.0000088027.54400.C6","volume":"14","author":"J Mishra","year":"2003","unstructured":"Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, et al. Identification of neutrophil gelatinase-associated Lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14:2534\u201343.","journal-title":"J Am Soc Nephrol"},{"key":"4085_CR26","doi-asserted-by":"publisher","first-page":"F552","DOI":"10.1152\/ajprenal.00285.2002","volume":"286","author":"T Ichimura","year":"2004","unstructured":"Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Ren Physiol. 2004;286:F552\u201363.","journal-title":"Am J Physiol Ren Physiol"},{"key":"4085_CR27","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1124\/jpet.112.192807","volume":"341","author":"K Hosohata","year":"2012","unstructured":"Hosohata K, Ando H, Fujimura A. Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury. J Pharmacol Exp Ther. 2012;341:656\u201362.","journal-title":"J Pharmacol Exp Ther"},{"key":"4085_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12882-022-02760-4","volume":"23","author":"M Yanishi","year":"2022","unstructured":"Yanishi M, Kinoshita H. Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury. BMC Nephrol. 2022;23:125.","journal-title":"BMC Nephrol"},{"key":"4085_CR29","first-page":"306","volume":"9","author":"F Shahbazi","year":"2015","unstructured":"Shahbazi F, Sadighi S, Dashti-Khavidaki S, Shahi F, Mirzania M. Urine ratio of neutrophil gelatinase-associated Lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity. Iran J Kidney Dis. 2015;9:306\u201310.","journal-title":"Iran J Kidney Dis"},{"key":"4085_CR30","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1177\/1078155220901756","volume":"26","author":"E Ghadrdan","year":"2020","unstructured":"Ghadrdan E, Ebrahimpour S, Sadighi S, Chaibakhsh S, Jahangard-Rafsanjani Z. Evaluation of urinary neutrophil gelatinase-associated Lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin. J Oncol Pharm Pract. 2020;26:1643\u20139.","journal-title":"J Oncol Pharm Pract"},{"key":"4085_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1620\/tjem.254.163","volume":"254","author":"T Yamazoe","year":"2021","unstructured":"Yamazoe T, Akagawa S, Matsuno R, et al. Superiority of Cystatin C over creatinine for early diagnosis of acute kidney injury in pediatric acute lymphoblastic leukemia\/lymphoblastic lymphoma. Tohoku J Exp Med. 2021;254:163\u201370.","journal-title":"Tohoku J Exp Med"},{"key":"4085_CR32","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/s41390-022-02015-w","volume":"92","author":"AAS Mahmoud","year":"2022","unstructured":"Mahmoud AAS, Elsalam HBA, El-Deeb SM, Zanaty FM, Aboelghar HM, Elharoun MS. Evaluation of kidney dysfunction in childhood cancer survivors. Pediatr Res. 2022;92:1689\u201394.","journal-title":"Pediatr Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04085-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04085-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04085-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T17:04:21Z","timestamp":1743181461000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04085-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4085"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04085-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional research committee at which the studies were conducted (approval number 29\/IV-10) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from the parents or legal guardian of each participant included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}